SteadyMed Therapeutics

SteadyMed Therapeutics

SteadyMed Therapeutics

SteadyMed aspires to redefine the parenteral therapeutics experience for patients dependent upon large doses of intravenous and subcutaneous medications.
Type
B2c
Founded
2005
Raised
$77.4M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$32,000,000
Post-IPO equity - 2016
OrbiMed Deerfield Capital Management Federated Investors
Team Size
10+
Employees
Location
Headquarters
$30,000,000 Post-IPO equity
Drug Delivery Business , NoCamels - Israeli Tech and Innovation News

SteadyMed raises $30m for Trevyent commercial launch